BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+25.36%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$2.46B
AUM Growth
+$2.46B
(+17%)
Cap. Flow
+$42M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
75.82%
Holding
26
New
2
Increased
7
Reduced
9
Closed
–
Top Buys
| 1 |
Agios Pharmaceuticals
AGIO
|
$84.9M |
| 2 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$39.6M |
| 3 |
Novavax
NVAX
|
$31.3M |
| 4 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$13.4M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$12.5M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$73.8M |
| 2 |
CELG
Celgene Corp
CELG
|
$31.3M |
| 3 |
Puma Biotechnology
PBYI
|
$23.9M |
| 4 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$10.8M |
| 5 |
MDVN
MEDIVATION, INC.
MDVN
|
$6.92M |
Sector Composition
| 1 | Healthcare | 83.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $369M | 14.99% | 3,889,298 -330,000 | -8% | -$31.3M |
|
|
2
Gilead Sciences
GILD
$140B
| $298M | 12.1% | 2,795,596 -692,900 | -20% | -$73.8M |
|
3
Ionis Pharmaceuticals
IONS
$6.79B
| $258M | 10.48% | 6,636,526 -70,000 | -1% | -$2.72M |
|
4
Incyte
INCY
$16.5B
| $211M | 8.58% | 4,301,867 +138,077 | +3% | +$6.77M |
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $152M | 6.19% | 1,354,445 -50,000 | -4% | -$5.62M |
|
|
MDVN
6
DELISTED
MEDIVATION, INC.
MDVN
| $141M | 5.75% | 1,429,706 -70,000 | -5% | -$6.92M |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $121M | 4.9% | 727,428 | – | – |
|
|
8
Agios Pharmaceuticals
AGIO
$2.19B
| $116M | 4.72% | 1,890,521 +1,384,521 | +274% | +$84.9M |
|
|
9
Puma Biotechnology
PBYI
$254M
| $114M | 4.63% | 476,991 -100,000 | -17% | -$23.9M |
|
|
PCYC
10
DELISTED
PHARMACYCLICS INC
PCYC
| $85.9M | 3.49% | 731,542 | – | – |
|
11
Regeneron Pharmaceuticals
REGN
$61.5B
| $84M | 3.42% | 233,000 | – | – |
|
|
GEVA
12
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $75.2M | 3.06% | 1,093,476 +195,000 | +22% | +$13.4M |
|
|
13
Alnylam Pharmaceuticals
ALNY
$58.5B
| $61M | 2.48% | 781,288 +160,000 | +26% | +$12.5M |
|
14
Halozyme
HALO
$8.56B
| $58.5M | 2.38% | 6,430,532 +583,968 | +10% | +$5.31M |
|
|
RDUS
15
DELISTED
Radius Health, Inc.
RDUS
| $57.6M | 2.34% | 2,745,040 | – | – |
|
16
Neurocrine Biosciences
NBIX
$13.8B
| $48.8M | 1.99% | 3,116,552 +30,000 | +1% | +$470K |
|
|
RCPT
17
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $39.6M | 1.61% | +636,773 | New | +$39.6M |
|
|
IMGN
18
DELISTED
Immunogen Inc
IMGN
| $33.5M | 1.36% | 3,165,816 | – | – |
|
|
19
Novavax
NVAX
$1.21B
| $31.3M | 1.27% | +7,500,000 | New | +$31.3M |
|
|
INFI
20
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $31.1M | 1.27% | 2,320,737 +815,000 | +54% | +$10.9M |
|
|
CLVS
21
DELISTED
Clovis Oncology, Inc.
CLVS
| $25.3M | 1.03% | 558,188 | – | – |
|
|
TSRO
22
DELISTED
TESARO, Inc.
TSRO
| $19M | 0.77% | 704,582 | – | – |
|
|
ACHN
23
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $12.8M | 0.52% | 1,279,340 -500,000 | -28% | -$4.99M |
|
24
Innoviva
INVA
$1.29B
| $12.7M | 0.52% | 743,244 -190,000 | -20% | -$3.25M |
|
|
ECYT
25
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $4.16M | 0.17% | 683,522 -1,780,000 | -72% | -$10.8M |
|